| 0 |
KALEIDOSCOPE VISION |
1 |
0.0312 |
| 1 |
PRIMARY IMMUNODEFICIENCY SYNDROME |
1 |
0.0123 |
| 2 |
SHUNT THROMBOSIS |
1 |
0.0101 |
| 3 |
MIDDLE CEREBRAL ARTERY STROKE |
1 |
0.0088 |
| 4 |
IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME |
1 |
0.0066 |
| 5 |
IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY |
1 |
0.0057 |
| 6 |
CEREBRAL MASS EFFECT |
1 |
0.0028 |
| 7 |
PERIPHERAL CIRCULATORY FAILURE |
1 |
0.0024 |
| 8 |
HYPERTENSIVE URGENCY |
1 |
0.0018 |
| 9 |
HYPERTENSIVE EMERGENCY |
2 |
0.0017 |
| 10 |
INFUSION SITE URTICARIA |
1 |
0.0015 |
| 11 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
1 |
0.0012 |
| 12 |
TONGUE PRURITUS |
1 |
0.0012 |
| 13 |
TRANSFUSION REACTION |
1 |
0.0011 |
| 14 |
ANAPHYLACTOID REACTION |
4 |
0.0010 |
| 15 |
CHRONIC RESPIRATORY FAILURE |
1 |
0.0008 |
| 16 |
INFUSION RELATED REACTION |
49 |
0.0007 |
| 17 |
URTICARIA |
122 |
0.0007 |
| 18 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 19 |
PULMONARY SEPSIS |
1 |
0.0007 |
| 20 |
MENINGITIS ASEPTIC |
3 |
0.0007 |
| 21 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 22 |
COSTOCHONDRITIS |
1 |
0.0006 |
| 23 |
LIP SWELLING |
19 |
0.0006 |
| 24 |
AORTIC VALVE STENOSIS |
1 |
0.0006 |
| 25 |
ANAL PRURITUS |
1 |
0.0005 |
| 26 |
SENSATION OF FOREIGN BODY |
4 |
0.0005 |
| 27 |
ORAL PRURITUS |
1 |
0.0004 |
| 28 |
PUSTULE |
1 |
0.0004 |
| 29 |
PHARYNGEAL SWELLING |
4 |
0.0004 |
| 30 |
HYPERVOLAEMIA |
2 |
0.0004 |
| 31 |
PARTIAL SEIZURES |
2 |
0.0004 |
| 32 |
METABOLIC DISORDER |
2 |
0.0003 |
| 33 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 34 |
RESPIRATORY ACIDOSIS |
1 |
0.0003 |
| 35 |
LIP OEDEMA |
1 |
0.0002 |
| 36 |
EAR DISORDER |
1 |
0.0002 |
| 37 |
RECALLED PRODUCT ADMINISTERED |
2 |
0.0002 |
| 38 |
RASH VESICULAR |
1 |
0.0002 |
| 39 |
PRURITUS |
78 |
0.0002 |
| 40 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 41 |
MOTOR DYSFUNCTION |
2 |
0.0002 |
| 42 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 43 |
HYPERTENSIVE CRISIS |
2 |
0.0002 |
| 44 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 45 |
MOUTH SWELLING |
1 |
0.0002 |
| 46 |
SWELLING FACE |
11 |
0.0002 |
| 47 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
1 |
0.0002 |
| 48 |
POLYNEUROPATHY |
2 |
0.0002 |
| 49 |
ANAPHYLACTIC REACTION |
9 |
0.0002 |
| 50 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 51 |
DERMATITIS ALLERGIC |
2 |
0.0002 |
| 52 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 53 |
PAPULE |
1 |
0.0001 |
| 54 |
ANGIOEDEMA |
6 |
0.0001 |
| 55 |
RASH |
59 |
0.0001 |
| 56 |
TENDON PAIN |
1 |
0.0001 |
| 57 |
HAEMOLYSIS |
1 |
0.0001 |
| 58 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 59 |
MIOSIS |
1 |
0.0001 |
| 60 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 61 |
COLD SWEAT |
2 |
0.0001 |
| 62 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 63 |
THROAT IRRITATION |
5 |
0.0001 |
| 64 |
RASH PRURITIC |
6 |
0.0001 |
| 65 |
UROSEPSIS |
1 |
0.0001 |
| 66 |
CHEST DISCOMFORT |
11 |
0.0001 |
| 67 |
HYPERSENSITIVITY |
19 |
0.0001 |
| 68 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 69 |
FLUSHING |
9 |
0.0001 |
| 70 |
WHEEZING |
5 |
0.0001 |
| 71 |
CHILLS |
9 |
0.0001 |
| 72 |
JAUNDICE |
2 |
0.0001 |
| 73 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 74 |
TACHYPNOEA |
1 |
0.0001 |
| 75 |
PALLOR |
2 |
0.0001 |
| 76 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 77 |
PAIN IN JAW |
2 |
0.0001 |
| 78 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 79 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 80 |
ERYTHEMA |
13 |
0.0001 |
| 81 |
RASH ERYTHEMATOUS |
3 |
0.0001 |
| 82 |
CHEST PAIN |
11 |
0.0001 |
| 83 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 84 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 85 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 86 |
THIRST |
1 |
0.0001 |
| 87 |
PELVIC PAIN |
1 |
0.0001 |
| 88 |
EAR PAIN |
1 |
0.0001 |
| 89 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 90 |
TASTE DISORDER |
1 |
0.0000 |
| 91 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 92 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 93 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 94 |
ORAL PAIN |
1 |
0.0000 |
| 95 |
SNEEZING |
1 |
0.0000 |
| 96 |
CHROMATURIA |
1 |
0.0000 |
| 97 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 98 |
SKIN BURNING SENSATION |
3 |
0.0000 |
| 99 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 100 |
THERAPY CESSATION |
2 |
0.0000 |
| 101 |
OFF LABEL USE |
34 |
0.0000 |
| 102 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 103 |
ECZEMA |
2 |
0.0000 |
| 104 |
SPEECH DISORDER |
2 |
0.0000 |
| 105 |
DYSPNOEA |
21 |
0.0000 |
| 106 |
HEADACHE |
23 |
0.0000 |
| 107 |
SKIN LESION |
1 |
0.0000 |
| 108 |
PRODUCT USE IN UNAPPROVED INDICATION |
9 |
0.0000 |
| 109 |
BLISTER |
2 |
0.0000 |
| 110 |
ANGINA PECTORIS |
1 |
0.0000 |
| 111 |
PANCREATIC CARCINOMA |
1 |
0.0000 |
| 112 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 113 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 114 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 115 |
FEELING HOT |
2 |
0.0000 |
| 116 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 117 |
DYSPHAGIA |
3 |
0.0000 |
| 118 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 119 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 120 |
HYPERHIDROSIS |
4 |
0.0000 |
| 121 |
HEART RATE INCREASED |
3 |
0.0000 |
| 122 |
TREMOR |
5 |
0.0000 |
| 123 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 124 |
SKIN DISORDER |
1 |
0.0000 |
| 125 |
EYE PRURITUS |
1 |
0.0000 |
| 126 |
NAUSEA |
23 |
0.0000 |
| 127 |
RASH MACULAR |
1 |
0.0000 |
| 128 |
HEART RATE DECREASED |
1 |
0.0000 |
| 129 |
RESTLESSNESS |
1 |
0.0000 |
| 130 |
EYE SWELLING |
1 |
0.0000 |
| 131 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 132 |
SEIZURE |
3 |
0.0000 |
| 133 |
PALPITATIONS |
3 |
0.0000 |
| 134 |
DISORIENTATION |
1 |
0.0000 |
| 135 |
VOMITING |
11 |
0.0000 |
| 136 |
BALANCE DISORDER |
2 |
0.0000 |
| 137 |
SEPTIC SHOCK |
1 |
0.0000 |
| 138 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 139 |
TACHYCARDIA |
2 |
0.0000 |
| 140 |
TINNITUS |
1 |
0.0000 |
| 141 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 142 |
BACK PAIN |
5 |
0.0000 |
| 143 |
COUGH |
6 |
0.0000 |
| 144 |
ARRHYTHMIA |
1 |
0.0000 |
| 145 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 146 |
DYSPEPSIA |
2 |
0.0000 |
| 147 |
HYPOTENSION |
4 |
0.0000 |
| 148 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 149 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 150 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 151 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 152 |
NECK PAIN |
1 |
0.0000 |
| 153 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 154 |
LETHARGY |
1 |
0.0000 |
| 155 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 156 |
DYSPHONIA |
1 |
0.0000 |
| 157 |
DISCOMFORT |
1 |
0.0000 |
| 158 |
MALAISE |
7 |
0.0000 |
| 159 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 160 |
HYPERTENSION |
3 |
0.0000 |
| 161 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 162 |
EPISTAXIS |
1 |
0.0000 |
| 163 |
HYPOAESTHESIA |
2 |
0.0000 |
| 164 |
ASTHENIA |
5 |
0.0000 |
| 165 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 166 |
DECREASED APPETITE |
3 |
0.0000 |
| 167 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 168 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 169 |
FATIGUE |
9 |
0.0000 |
| 170 |
SWELLING |
1 |
0.0000 |
| 171 |
MIGRAINE |
1 |
0.0000 |
| 172 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 173 |
DIZZINESS |
5 |
0.0000 |
| 174 |
SOMNOLENCE |
2 |
0.0000 |
| 175 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 176 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 177 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 178 |
NEUTROPENIA |
1 |
0.0000 |
| 179 |
ANXIETY |
2 |
0.0000 |
| 180 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 181 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 182 |
MYALGIA |
1 |
0.0000 |
| 183 |
PYREXIA |
2 |
0.0000 |
| 184 |
ARTHRALGIA |
2 |
0.0000 |
| 185 |
DIARRHOEA |
3 |
0.0000 |
| 186 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 187 |
FEELING ABNORMAL |
1 |
0.0000 |
| 188 |
PAIN |
2 |
0.0000 |
| 189 |
DRUG INEFFECTIVE |
2 |
0.0000 |